These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1314 related items for PubMed ID: 16815744

  • 21. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
    Riemann D, Voderholzer U, Cohrs S, Rodenbeck A, Hajak G, Rüther E, Wiegand MH, Laakmann G, Baghai T, Fischer W, Hoffmann M, Hohagen F, Mayer G, Berger M.
    Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
    [Abstract] [Full Text] [Related]

  • 22. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
    Staner L, Eriksson M, Cornette F, Santoro F, Muscat N, Luthinger R, Roth T.
    Sleep Med; 2009 Jun; 10(6):616-20. PubMed ID: 18996742
    [Abstract] [Full Text] [Related]

  • 23. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
    Luthringer R, Muzet M, Zisapel N, Staner L.
    Int Clin Psychopharmacol; 2009 Sep; 24(5):239-49. PubMed ID: 19584739
    [Abstract] [Full Text] [Related]

  • 24. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.
    Blin O, Micallef J, Audebert C, Legangneux E.
    J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893
    [Abstract] [Full Text] [Related]

  • 25. Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.
    Voshaar RC, van Balkom AJ, Zitman FG.
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):301-6. PubMed ID: 15163440
    [Abstract] [Full Text] [Related]

  • 26. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [Abstract] [Full Text] [Related]

  • 27. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.
    Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW.
    Arch Intern Med; 2004 Sep 27; 164(17):1888-96. PubMed ID: 15451764
    [Abstract] [Full Text] [Related]

  • 28. An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults.
    Rosenberg R, Caron J, Roth T, Amato D.
    Sleep Med; 2005 Jan 27; 6(1):15-22. PubMed ID: 15680290
    [Abstract] [Full Text] [Related]

  • 29. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
    Jhaveri M, Seal B, Pollack M, Wertz D.
    Curr Med Res Opin; 2007 Jun 27; 23(6):1431-43. PubMed ID: 17559740
    [Abstract] [Full Text] [Related]

  • 30. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T, ZOLONG Study Group.
    Sleep; 2008 Jan 27; 31(1):79-90. PubMed ID: 18220081
    [Abstract] [Full Text] [Related]

  • 31. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R, Murphy P, Zammit G, Mayleben D, Kumar D, Dhadda S, Filippov G, LoPresti A, Moline M.
    JAMA Netw Open; 2019 Dec 02; 2(12):e1918254. PubMed ID: 31880796
    [Abstract] [Full Text] [Related]

  • 32. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.
    Uchimura N, Kamijo A, Kuwahara H, Uchiyama M, Shimizu T, Chiba S, Inoue Y.
    Sleep Med; 2012 Dec 02; 13(10):1247-53. PubMed ID: 23063301
    [Abstract] [Full Text] [Related]

  • 33. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL.
    Am J Ther; 2007 Dec 02; 14(3):299-305. PubMed ID: 17515707
    [Abstract] [Full Text] [Related]

  • 34. Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia.
    Staner C, Joly F, Jacquot N, Vlasova ID, Nehlin M, Lundqvist T, Edenius C, Staner L.
    Curr Med Res Opin; 2010 Jun 02; 26(6):1423-31. PubMed ID: 20397964
    [Abstract] [Full Text] [Related]

  • 35. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA.
    Sleep Med; 2005 Nov 02; 6(6):487-95. PubMed ID: 16230048
    [Abstract] [Full Text] [Related]

  • 36. Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia.
    Walsh JK, Zammit G, Schweitzer PK, Ondrasik J, Roth T.
    Sleep Med; 2006 Mar 02; 7(2):155-61. PubMed ID: 16260179
    [Abstract] [Full Text] [Related]

  • 37. Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia.
    Walsh JK, Perlis M, Rosenthal M, Krystal A, Jiang J, Roth T.
    J Clin Sleep Med; 2006 Jan 15; 2(1):35-41. PubMed ID: 17557435
    [Abstract] [Full Text] [Related]

  • 38. Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.
    Roehrs TA, Roth T.
    J Clin Sleep Med; 2016 Mar 15; 12(3):319-25. PubMed ID: 26446253
    [Abstract] [Full Text] [Related]

  • 39. Quetiapine for primary insomnia: a double blind, randomized controlled trial.
    Tassniyom K, Paholpak S, Tassniyom S, Kiewyoo J.
    J Med Assoc Thai; 2010 Jun 15; 93(6):729-34. PubMed ID: 20572379
    [Abstract] [Full Text] [Related]

  • 40. Double blind comparison of zolpidem 20 mg versus flunitrazepam 2 mg in insomniac in-patients.
    Frattola L, Maggioni M, Cesana B, Priore P.
    Drugs Exp Clin Res; 1990 Jun 15; 16(7):371-6. PubMed ID: 2092963
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 66.